NO20002176L - Diagnostikk og terapi av kronisk obstruktiv luftveissykdom - Google Patents

Diagnostikk og terapi av kronisk obstruktiv luftveissykdom

Info

Publication number
NO20002176L
NO20002176L NO20002176A NO20002176A NO20002176L NO 20002176 L NO20002176 L NO 20002176L NO 20002176 A NO20002176 A NO 20002176A NO 20002176 A NO20002176 A NO 20002176A NO 20002176 L NO20002176 L NO 20002176L
Authority
NO
Norway
Prior art keywords
chronic obstructive
diagnosis
therapy
obstructive airway
airway disease
Prior art date
Application number
NO20002176A
Other languages
English (en)
Norwegian (no)
Other versions
NO20002176D0 (no
Inventor
Gordon W Duff
Marco Giovine
Peter J Barnes
Simon Lim
Original Assignee
Interleukin Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9723553.5A external-priority patent/GB9723553D0/en
Application filed by Interleukin Genetics Inc filed Critical Interleukin Genetics Inc
Publication of NO20002176D0 publication Critical patent/NO20002176D0/no
Publication of NO20002176L publication Critical patent/NO20002176L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/172Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20002176A 1997-11-07 2000-04-27 Diagnostikk og terapi av kronisk obstruktiv luftveissykdom NO20002176L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9723553.5A GB9723553D0 (en) 1997-11-07 1997-11-07 Prediction of the risk of chronic obstructive airway disease
US09/005,923 US6140047A (en) 1997-11-07 1998-01-12 Method and kit for predicting susceptibility to asthma
PCT/US1998/023721 WO1999024615A2 (en) 1997-11-07 1998-11-09 Diagnostics and therapeutics for chronic obstructive airway disease

Publications (2)

Publication Number Publication Date
NO20002176D0 NO20002176D0 (no) 2000-04-27
NO20002176L true NO20002176L (no) 2000-07-05

Family

ID=26312564

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002176A NO20002176L (no) 1997-11-07 2000-04-27 Diagnostikk og terapi av kronisk obstruktiv luftveissykdom

Country Status (13)

Country Link
EP (1) EP1029079B1 (es)
JP (1) JP2001522586A (es)
AT (1) ATE383438T1 (es)
AU (1) AU760856B2 (es)
BR (1) BR9813950A (es)
CA (1) CA2308570A1 (es)
ES (1) ES2297900T3 (es)
HU (1) HUP0301197A2 (es)
IL (1) IL135957A0 (es)
NO (1) NO20002176L (es)
PL (1) PL340624A1 (es)
TR (1) TR200001263T2 (es)
WO (1) WO1999024615A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6251598B1 (en) 1998-10-30 2001-06-26 Interleukin Genetics, Inc. Methods for diagnosing sepsis
JP2002540801A (ja) * 1999-04-02 2002-12-03 インタールーキン ジェネティックス インク 間質性肺疾患の危険性の予測
AU7706000A (en) * 1999-09-22 2001-04-24 Genaissance Pharmaceuticals, Inc. Drug target isogenes: polymorphisms in the interleukin-1 beta gene
US20030124524A1 (en) * 2000-06-23 2003-07-03 Kenneth Kornman Screening assays for identifying modulators of the inflammatory or immune response
US20050159590A1 (en) * 2003-08-25 2005-07-21 Galit Rotman Variants of interleukin-1 receptor antagonist: compositions and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995001997A1 (en) * 1993-07-09 1995-01-19 Smithkline Beecham Corporation RECOMBINANT AND HUMANIZED IL-1β ANTIBODIES FOR TREATMENT OF IL-1 MEDIATED INFLAMMATORY DISORDERS IN MAN
US5674483A (en) * 1995-01-31 1997-10-07 National Jewish Medical And Research Center Treatment for diseases involving inflammation
US5686246A (en) * 1995-08-03 1997-11-11 Kornman; Kenneth S. Detecting genetic predisposition to periodontal disease
GB9711040D0 (en) * 1997-05-29 1997-07-23 Duff Gordon W Prediction of inflammatory disease

Also Published As

Publication number Publication date
AU1386399A (en) 1999-05-31
BR9813950A (pt) 2000-09-26
IL135957A0 (en) 2001-05-20
EP1029079B1 (en) 2008-01-09
EP1029079A2 (en) 2000-08-23
WO1999024615A2 (en) 1999-05-20
PL340624A1 (en) 2001-02-12
CA2308570A1 (en) 1999-05-20
ATE383438T1 (de) 2008-01-15
HUP0301197A2 (hu) 2003-07-28
JP2001522586A (ja) 2001-11-20
NO20002176D0 (no) 2000-04-27
ES2297900T3 (es) 2008-05-01
AU760856B2 (en) 2003-05-22
TR200001263T2 (tr) 2000-12-21
WO1999024615A3 (en) 1999-09-16

Similar Documents

Publication Publication Date Title
ATE324119T1 (de) Verwendung von saccharid-konjugaten
DK1041967T3 (da) Mikropartikler og deres terapeutiske eller diagnostiske anvendelse
IT1303244B1 (it) Procedimento per l'installazione e la verifica del software per unsistema di computer prodotto su ordinazione.
FI20000720L (fi) Pitkitettyyn vapautumiseen perustuva tablettiformulaatio Parkisonin taudin hoitamiseksi
DE69007732D1 (de) Befestigungsvorrichtung für Computerperipherien.
DE69625597D1 (de) I/o-prozessor architektur mit integrierter pci-pci brücke
DE69627814D1 (de) System zum bereitstellen eines bios für den hauptrechner
IT1303245B1 (it) Apparecchio per facilitare l'installazione e la verifica del softwareper un sistema di computer prodotto su ordinazione.
PT1333887E (pt) Metodo de tratamento de desordens musculares
KR970702736A (ko) 비강용 투약기(Medicine Administering Device for Nasal Cavities)
DE69837461D1 (de) Rechner Systemverwaltung über das Internet
EP2275959A3 (en) Method of screening a therapeutic agent for therapeutic effectiveness
DE69633645D1 (de) Vorrichtung zum Verabreichen von Medikamenten
KR950012484U (ko) 컴퓨터 주변기기용 체결장치
KR960032380U (ko) 컴퓨터 케이스의 체결장치
AU6416198A (en) Diagnostic means useful for predictive assessment of human hepatocellular carc inoma disease (hcc), as well as diagnostic methods using the same
NO994915L (no) Fremgangsmåter for diagnostisering av kliniske undertyper av Crohn's sykdom med karakteristisk evne til å gi respons på anti-Thl-cytokinterapi
AU2991697A (en) Methods of diagnosing clinical subtypes of crohn's disease
BR9607544A (pt) Fluximetro de massa com efeito coriolos que usa rotores concêntricos
EP0723460A4 (en) GENE THERAPY CONCERNING THE NERVOUS SYSTEM
DE69601813D1 (de) Fehlertolerante Rechnervorrichtung
EP0883809A4 (en) METHOD FOR DIAGNOSTIC PROSTATE ADENOCARCINOMAS
ID21534A (id) Konstruksi asam nukleat untuk terapi gen dimana aktifitasnya dipengaruhi oleh inhibitor kinase yang tergantung pada siklin
NO20002176L (no) Diagnostikk og terapi av kronisk obstruktiv luftveissykdom
EP0693183A4 (en) METHOD FOR DETERMINING DIABETES SENSITIVITY IN ASYMPTOMATIC PATIENTS

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application